Cargando…
Successful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report
A 46-year-old man who had undergone hematopoietic stem cell transplant twice because of acute lymphoblastic leukemia with recurrence presented with dyspnea, leading to a diagnosis of pulmonary arterial hypertension which was quickly and effectively treated with the phosphodiesterase type 5 inhibitor...
Autores principales: | Tanaka, Toshikazu D., Ishizawar, David C., Saito, Takeshi, Yoshii, Akira, Yoshimura, Michihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243114/ https://www.ncbi.nlm.nih.gov/pubmed/34262695 http://dx.doi.org/10.1177/20458940211027791 |
Ejemplares similares
-
The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
por: Falk, Jeremy A, et al.
Publicado: (2010) -
Reversal of pulmonary arterial hypertension in POEMS syndrome with thalidomide: a case report
por: Tanaka, Toshikazu D, et al.
Publicado: (2018) -
Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020) -
Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension
por: Katz, Stuart D.
Publicado: (2007) -
Tadalafil Nanoemulsion Mists for Treatment of Pediatric Pulmonary Hypertension via Nebulization
por: Elbardisy, Bassant, et al.
Publicado: (2022)